Insilico Medicine Cayman Topco Stock Forecast

Sell candidate since Aug 11, 2026

The Insilico Medicine Cayman Topco stock price fell by -0.99% on the last day (Tuesday, 11th Aug 2026) from HK$48.48 to HK$48.00. During the last trading day the stock fluctuated 6.91% from a day low at HK$47.00 to a day high of HK$50.25. The price has been going up and down for this period, and there has been a 11.89% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -9 million shares and in total, 16 million shares were bought and sold for approximately HK$771.68 million.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at HK$49.83 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -7.09% during the next 3 months and, with a 90% probability hold a price between HK$28.38 and HK$46.30 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

3696.HK Signals & Forecast

The Insilico Medicine Cayman Topco stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$44.13 and HK$43.22. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 15, 2026, and so far it has fallen -5.88%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Insilico Medicine Cayman Topco stock

On the downside, the stock finds support just below today's level from accumulated volume at HK$45.44 and HK$39.62. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Insilico Medicine Cayman Topco finds support just below today's level at HK$45.44. If this is broken, then the next support from accumulated volume will be at HK$39.62 and HK$37.38.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$3.25 between high and low, or 6.91%. For the last week, the stock has had daily average volatility of 8.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (3696.HK) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Insilico Medicine Cayman Topco to open at HK$48.42, and during the day (based on 14 day Average True Range), to move between HK$45.83 and HK$50.17, which gives a possible trading interval of +/-HK$4.33 (+/-9.45%) up or down from last closing price. If Insilico Medicine Cayman Topco takes out the full calculated possible swing range there will be an estimated 9.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$48.48 (1.00%) than the support at HK$45.44 (5.33%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Insilico Medicine Cayman Topco stock A Buy?

Insilico Medicine Cayman Topco holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.285 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - HK$48.42 ( 0.87%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk